
The CCS partnered with renowned cardiovascular specialists and patient organizations including the Ted Rogers Centre for Heart Research, the CHFS, The Heart Hub, and Heart Life Foundation to launch a first-of-its-kind patient guide about heart failure (HF) medications.
This novel patient guide was developed with and for people who live with heart failure with reduced ejection fraction (HFrEF), emphasizing the important role of HF medications to extend and improve the quality of patients’ lives. It was developed using information from the 2021 CCS/CHFS HF Guidelines. The site includes a suite of tools, videos and infographics to help people learn more about medications and their care, and support conversations with their healthcare team.
Visit ourhearthub.ca/heart-failure-medications-guide/ to learn more and see Heart Failure Medications: A Patient & Caregiver Guide in action.
Other News
See AllThe CCS Celebrates Recent Passing of The Heart Valve Disease Awareness Act (Bill 66)
February 6, 2025
The CCS is proud to highlight the Legislative Assembly of Ontario’s recent passing of The Heart...
CCS NewsTake a Peek at What CCS Leadership Has in Store for CCC 2024!
September 25, 2024
The CCS Leadership team will be all over CCC – don’t miss your chance to connect and see...
Canadian Cardiovascular Congress CCS Leadership CCS NewsCongratulations to the Recipients of the 2024 CCS Recognition Awards!
August 22, 2024
Each year, the CCS recognizes the outstanding achievements of individual Canadians and Canadian...
CCS News CCS Recognition Awards